Catalyst Wire Dossier Catalyst Wire Dossier

Quadripolar left ventricular lead for cardiac resynchronization therapy

· Abbott Medical Devices
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quadripolar left ventricular lead for cardiac resynchronization therapy, covering 2019-02-04 to 2019-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchronization Patients With Quadripolar Left Ventricular Leads

See pricing